Cargando…
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use
In the past two decades, microRNAs have emerged as crucial mediators of organ development and human disease. Here, we discuss their role as drivers or suppressors of the hallmarks of cancer during tumorigenesis and progression, in defining interpatient heterogeneity and the promise of therapeutic ap...
Autores principales: | Nana-Sinkam, S Patrick, Croce, Carlo M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709998/ https://www.ncbi.nlm.nih.gov/pubmed/25315999 http://dx.doi.org/10.1186/s13059-014-0445-8 |
Ejemplares similares
-
The Role of microRNAs in the Tumorigenesis of Ovarian Cancer
por: Di Leva, Gianpiero, et al.
Publicado: (2013) -
microRNAs as Novel Therapeutics in Cancer
por: Romano, Giulia, et al.
Publicado: (2021) -
Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
por: Hoffmann, Oliver Ingo, et al.
Publicado: (2022) -
A Mathematical Model for MicroRNA in Lung Cancer
por: Kang, Hye-Won, et al.
Publicado: (2013) -
MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
por: Zhao, Lin, et al.
Publicado: (2016)